DEC 03, 2018 09:31 AM PST

Endocannabinoids Are So Promiscuous

WRITTEN BY: Amy Loriaux

When we think about the endocannabinoid system (ECS) (the body's system of neurotransmitters, receptors, and enzymes that are highjacked by the chemicals in cannabis) we tend to think about four pieces of it: the neurotransmitters (NTs) anandamide and 2-AG and the receptors CB1 and CB2. Out-dated neuroscience theories posited that one neuron sends one NT and one NT can bind only to one receptor. While this may be (putatively) true for many NTs, like dopamine and serotonin, some NTs can interact with receptors outside of their "class". Also, some receptors can be activated by several different NTs. In scientific parlance, we called this "promiscuity" And guess what? It turns out that our ECS can be pretty promiscuous indeed!

Photo Source: Pixabay.com

Students in Neuroscience 101 are taught the "lock and key" relationship between NTs and their receptors. Well, imagine you have a skeleton key. That is what neuroscientists are starting to discover about our ECS; endocannabinoids are capable of not only activating CB1/2 but many other receptors as well. The implications for these interactions are just now starting to emerge. Let me introduce to you some of these "promiscuous" molecules busy soliciting in our ECS.

Transient receptor potential vanilloid (TRPV1) is a receptor that is activated by several NTs including anandamide. TRPV1 is promiscuous. Among its ligands are ECs and THC. TRPV1 activation in the spinal cord appears to regulate pain. There is a high degree of colocalization of CB1 and TRPV1 receptors on the cellular membrane. EC activity at this receptor could play a role in analgesia (pain reduction). GPR55 is another promiscuous receptor that is also involved in pain signaling. Synthetic ECs such as rimonabant and O-1602 bind to GPR55 and decrease neuropathic pain in rodents. While it is unknown whether ECs bind to GPR55, the fact that synthetic ECs are able to suggest that they may. 

Photo Source: Pixabay.com

ECs themselves are also capable of binding to receptors other than the "classic" CB1/2 receptors. Gamma-butyric acid (GABA) is the main inhibitory NT in the brain. The EC 2-AG can bind to GABA-A receptors to inhibit GABA release. Another receptor for an affinity for endocannabinoids is glycine. Glycine is similar to GABA but located mainly in the spinal cord and the peripheral nervous system. The phytocannabinoid THC has been shown to bind to glycine and potentiate their firing rate. This binding to the glycine receptor could mediate THC's analgesic effects from within the spinal cord.

This promiscuity is actually a good thing. It gives scientists more possible targets to treat various ailments, such as neuropathic pain. Not only do these findings provide novel clinical treatments, but it helps us to better understand this complex and dynamic system within us known as the ECS.

Sources: www.leafly.com, LabRoots.com, British Journal of Pharmacology, Neuroscience, Vol 2, www.khanacademy.org, Pain, https://en.wikipedia.org/wiki/TRPVMolecular Pain, Life Sciences, Cannabis and Cannabinoid Research, Nature Chemical Biology

 

 

About the Author
  • I am passionate about science. My specialties include neuroscience and psychology. I have over 10 years of biomedical neuroscience research at Arizona State University and the University of Texas at Southwestern Medical Center.
You May Also Like
SEP 13, 2018
Cannabis Sciences
SEP 13, 2018
The Physiology of the Munchies
It's known that marijuana makes people crave food in a phenomenon commonly called the munchies; until now, we didn't know much about why....
SEP 27, 2018
Cannabis Sciences
SEP 27, 2018
Will Legalization Lead to More Marijuana Use?
Before you celebrate another state's decision to legalize or otherwise decriminalize marijuana (if you are so inclined to do so), it may be a good idea...
OCT 23, 2018
Cannabis Sciences
OCT 23, 2018
Does Marijuana Help or Hinder Stroke Recovery?
A recent study reported in the Journal of Stroke and Cerebrovascular Diseases has found that marijuana smokers have a higher rate of hospital adm...
NOV 08, 2018
Cannabis Sciences
NOV 08, 2018
Government Needs to Allow More Research on Marijuana
When science is restricted, pseudoscience is allowed to roam free. The same can be said of marijuana research. From academics interested in our own endocan...
NOV 21, 2018
Cannabis Sciences
NOV 21, 2018
Intro to Phytocannabinoids
With the surge in public interest in marijuana due to state-by-state marijuana legislature reform have come two new chemical substances that have entered p...
JAN 09, 2019
Cannabis Sciences
JAN 09, 2019
Are CBDs Safe for Pregnant Women?
Cannabidiol (CBD) oils have been reported to have amazing health effects, from pain relief to anxiety relief to even cancer prevention. However, in using a...
Loading Comments...